Dissolution Testing – Drug Release Profiling

  • Home
  • Service
  • Dissolution Testing – Drug Release Profiling

Dissolution Testing – Drug Release Profiling

Overview:
Dissolution Testing is a critical analytical procedure used to determine the rate and extent to which an active pharmaceutical ingredient (API) dissolves from a solid dosage form (e.g., tablet or capsule) into a solution. This test provides essential insights into the bioavailability, performance, and consistency of pharmaceutical products.

Test Description:
The dosage form is placed in a dissolution vessel containing simulated gastric or intestinal fluid, and agitated using a USP Dissolution Apparatus (commonly Apparatus 1 – basket, or Apparatus 2 – paddle). The concentration of the drug in the fluid is measured at specific time intervals to assess how quickly and completely it dissolves.

Purpose & Benefits:

  • Evaluate drug release profile and bioequivalence
  • Support formulation development and quality control
  • Ensure batch-to-batch consistency
  • Aid in regulatory submissions and compliance

Industries Served:

  • Pharmaceutical and Biotech Companies
  • Contract Research & Manufacturing Organizations (CROs/CMOs)
  • Generic Drug Manufacturers
  • Academic and Regulatory Institutions